- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01524471
Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders
February 1, 2012 updated by: Chinese University of Hong Kong
Spastic esophageal motility disorders induced significant symptoms including dysphagia, retrosternal pain and regurgitation.
Per oral endoscopic myotomy (P.O.E.M.) is a novel approach to perform myotomy through the esophagus with long submucosal tunnel.
This study aimed to investigate the feasibility and safety of P.O.E.M. and translate the techniques from animal study to clinical practice in human.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hong Kong, Hong Kong, 00000
- Recruiting
- Department of Surgery, Chinese University of Hong Kong
-
Contact:
- Philip WY Chiu, MD
- Phone Number: 26322627
- Email: philipchiu@surgery.cuhk.edu.hk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All patients with age ranged 18 to 80 who had primary esophageal motility disorders will be recruited. The primary motility disorders included: Achalasia, hypertensive LES, Nutcracker esophagus and Diffuse esophageal spasm.
Exclusion Criteria:
Patients will be excluded from this study with the followings -
- Pregnancy
- Informed consent not available
- Previous history of esophagectomy or mediastinal surgery
- Previous history of endoscopic resection for early esophageal cancers, including endoscopic mucosal resection and endoscopic submucosal dissection
- End-stage Achalasia with dilated esophagus more than 6cm on Barium swallow Investigations before and after POEM
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: POEM
Endoscopic Myotomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Dysphagia score
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Improvement in LES pressure
|
|
Eckhart score
|
|
Operative time
|
|
Length of myotomy
|
|
Time to resume diet
|
|
Morbidities
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2010
Primary Completion (Anticipated)
March 1, 2012
Study Completion
December 7, 2022
Study Registration Dates
First Submitted
February 1, 2012
First Submitted That Met QC Criteria
February 1, 2012
First Posted (Estimate)
February 2, 2012
Study Record Updates
Last Update Posted (Estimate)
February 2, 2012
Last Update Submitted That Met QC Criteria
February 1, 2012
Last Verified
January 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRE_2010.430
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Achalasia
-
Federico II UniversityRecruitingAchalasia | Indocyanine Green | Indocyanine Green (ICG) | Achalasia, EsophagealItaly
-
Cairo UniversityRecruitingAchalasia | Achalasia CardiaEgypt
-
Mayo ClinicTerminatedAchalasia | Esophageal Achalasia | Achalasia, EsophagealUnited States
-
Federico II UniversityCompleted
-
Asian Institute of Gastroenterology, IndiaCompleted
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingDysphagia | Cricopharyngeal AchalasiaChina
-
Baylor College of MedicineRecruitingEsophageal Motility Disorders | AchalasiaUnited States
-
Peking Union Medical College HospitalCompleted
-
Zeng ChanghaoRecruitingCricopharyngeal AchalasiaTaiwan
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType I Achalasia | Type II Achalasia | EGJ Outflow Obstruction Without Spastic/Hypercontractile FeaturesUnited States
Clinical Trials on Per Oral Endoscopic Myotomy
-
NYU Langone HealthCompleted
-
Massachusetts General HospitalCompleted
-
Asian Institute of Gastroenterology, IndiaCompleted
-
Chinese University of Hong KongCompletedAchalasia | Hypertensive LESHong Kong
-
Chinese University of Hong KongUnknownPrimary Esophageal Motility Disorders Including Achalasia and Hypertensive LESChina
-
Johns Hopkins UniversityCompletedDiabetic Gastroparesis | Idiopathic Gastroparesis | Gastroparesis PostoperativeUnited States
-
Assiut UniversityNot yet recruiting
-
IRCCS San RaffaeleNot yet recruitingGastroparesis | Gastroparesis Postoperative | Gastroparesis With Diabetes MellitusItaly
-
McMaster UniversityCompleted
-
University of ArkansasWithdrawn